Facial subunit composite tissue allografts in nonhuman primates: I. technical and immunosuppressive requirements for prolonged graft Survival

Plastic and Reconstructive Surgery

Volumn 123, Issue 2, 2009, Pages 493-501

  Barth, Rolf N ^a   Bluebond Langner, Rachel ^a   Nam, Arthur ^a   Stanwix, Matthew ^a   Shipley, Steven ^a   Bartlett, Stephen T ^a   Rodriguez, Eduardo D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ALLOGRAFT; ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE; CAROTID ARTERY; COMMON CAROTID ARTERY; COMPOSITE GRAFT; CONTINUOUS INFUSION; DISEASE FREE SURVIVAL; DRUG MEGADOSE; DRUG SAFETY; END TO SIDE ANASTOMOSIS; EXTERNAL JUGULAR VEIN; FEMALE; FEMORAL ARTERY; FEMORAL VEIN; GRAFT SURVIVAL; HETEROTOPIC TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; INTERNAL JUGULAR VEIN; LONG TERM CARE; LOW DRUG DOSE; MALE; MONKEY; MONOTHERAPY; MUSCLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; PRIMATE; PRIORITY JOURNAL; SKIN; VEIN BLOOD FLOW; VEIN THROMBOSIS; ANASTOMOSIS; ANIMAL; BONE TRANSPLANTATION; FACE; FACE MUSCLE; GRAFT REJECTION; JUGULAR VEIN; MACACA; MAGNETIC RESONANCE ANGIOGRAPHY; METHODOLOGY; RADIOGRAPHY; SKIN TRANSPLANTATION; TRANSPLANTATION; VASCULARIZATION;

ANASTOMOSIS, SURGICAL; ANIMALS; BONE TRANSPLANTATION; CAROTID ARTERY, COMMON; FACE; FACIAL MUSCLES; FEMALE; FEMORAL VEIN; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; JUGULAR VEINS; MACACA FASCICULARIS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MODELS, ANIMAL; SKIN TRANSPLANTATION; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 61449205357     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181954edd     Document Type: Article

References (31)

1. Devauchelle B, Badet L, Lengele B, et al. First human face allograft: Early report. Lancet 2006;368:203-209.
2. International Registry onHand and Composite Tissue Transplantation. Available at: http://www handregistry com/ default-noflash/English/World- Experience/world-CTA html 2008.
3. Ulusal BG, Ulusal AE, Ozmen S, Zins JE, Siemionow MZ. A new composite facial and scalp transplantation model in rats. Plast Reconstr Surg. 2003;112:1302-1311.
4. Yazici I, Unal S, Siemionow M. Composite hemiface/calvaria transplantation model in rats. Plast Reconstr Surg. 2006;118: 1321-1327.
5. Ozer K, Zielinski M, Siemionow M. New composite tissue allograft transplantation model in mouse with intravital microscopic evaluation of microcirculation. J Reconstr Microsurg. 2003;19:323-330.
6. Foster RD, Pham S, Li S, Aitouche A. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade. Transplantation 2003;76:988-994.
7. Quatra F, Lowenberg DW, Buncke H, et al. Induction of tolerance to composite tissue allograft in a rat model. Microsurgery 2006;26:573-578.
8. Mathes DW, Randolph MA, Solari M, et al. Split tolerance to a composite tissue allograft in a swine model. Transplantation 2003;75:25-31.
9. Pierson RN. Costimulation: Tolerance versus immunosup-pression. In Program and Abstracts of the American Transplant Congress 2007, San Francisco, Calif; May 5-9, 2007.
10. Salama AD, Womer KL, Sayegh MH. Clinical transplantation tolerance: Many rivers to cross. J Immunol. 2007;178:5419-5423.
11. Bontrop RE. Comparative genetics of MHC polymorphisms in different primate species: Duplications and deletions. Hum Immunol. 2006;67:388-397.
12. Dzuris JL, Sidney J,Appella E,Chesnut RW, Watkins DI, Sette A. Conserved MHC class I peptide binding motif between humans and rhesus macaques. J Immunol. 2000;164:283-291.
13. Lakkis FG, Sayegh MH. Memory T cells: A hurdle to immunologic tolerance. J Am Soc Nephrol. 2003;14:2402-2410.
14. Yue Y, Kaur A, Eberhardt M, et al. Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques. J Virol. 2007;81:1095-1109.
15. Siemionow M. Analysis of historical outcomes of composite tissue allograft transplants in nonhuman primates. Transplantation 2005;80:1374-1375.
16. Gold M, Randzio J, Knia H, et al. Transplantation of vascularized composite mandibular allografts in young cynomolgus monkeys. Ann Plast Surg. 1991;26:125-132.
17. Cendales LC, Xu H, Bacher J, Eckhaus MA, Kleiner DE, Kirk AD. Composite tissue allotransplantation: Development of a preclinical model in nonhuman primates. Transplantation 2005;80:1447-1454.
18. Silverman RP, Banks ND, Detolla L, et al. A heterotopic primate model for facial composite tissue transplantation. Ann Plast Surg. 2008;60:209-216.
19. Lupp A, Kuhn UD, Herwig R, et al. Cyclosporine A and tacrolimus: In vitro investigations on the differential interactions with the cytochrome P450 system in rat and human liver. Exp Toxicol Pathol. 2003;54:467-473.
20. Stark JH, Smit JA, Gridelli B. Sensitivity of baboon lymphocytes to cyclosporin A and FK 506: Relative resistance of alloactivated cells to CyA. Transpl Int. 1994;7:372-378.
21. Metcalfe S, Svvennsen R, Calne RY. FK506 and rapamycin: Differential sensitivity of human, baboon, cynomolgus monkey, dog and pig lymphocytes. Transpl Int. 1992;5(Suppl 1): S514-S515.
22. Eiras G, Imventarza O, Murase N, et al. Species differences in sensitivity of T lymphocytes to immunosuppressive effects of FK 506. Transplantation 1990;49:1170-1172.
23. Utsugi R, Barth RN, Lee R, et al. Induction of transplantation tolerance with a short course of tacrolimus (FK506): I. Rapid and stable tolerance to two-haplotype fully mhc-mismatched kidney allografts in miniature swine. Transplantation 2001; 71:1368-1379.
24. Vagefi PA, Barth RN, Yamamoto S, et al. Thymic dependent long-term acceptance of renal allografts in juvenile baboons treated with a short course of FK506. Am J Transplant. 2003; 3:316.
25. Hollingshead WH. Anatomy for Surgeons. 3rd ed. New York: Harper & Row; 2008.
26. Siemionow M, Unal S, Agaoglu G, Sari A. A cadaver study in preparation for facial allograft transplantation in humans: Part I. What are alternative sources for total facial defect coverage? Plast Reconstr Surg. 2006;117:864-872.
27. Siemionow M, Agaoglu G, Unal S. A cadaver study in preparation for facial allograft transplantation in humans: Part II. Mock facial transplantation. Plast Reconstr Surg. 2006;117: 876-885.
28. Ghobrial RM, Hsieh CB, Lerner S,et al. Technical challenges of hepatic venous outflow reconstruction in right lobe adult living donor liver transplantation. Liver Transpl. 2001;7:551-555.
29. Lee S, Park K, Hwang S, et al. Congestion of right liver graft in living donor liver transplantation. Transplantation 2001; 71:812-814.
30. Fan ST, Lo CM, Liu CL, Wang WX, Wong J. Safety and necessity of including the middle hepatic vein in the right lobe graft in adult-to-adult live donor liver transplantation. Ann Surg. 2003;238:137-148.
31. Sugawara Y, Makuuchi M, Sano K, et al. Vein reconstruction in modified right liver graft for living donor liver transplantation. Ann Surg. 2003;237:180-185.